Twenty 4‐acyl‐5‐pyrazolonato (Q) titanium derivatives of varied nuclearity have been synthesized from Ti(OR)4 or TiCl4 and characterized with spectroscopic methods (IR, NMR, ESI‐MS). While Ti−(β‐diketonato) cleavage is not seen in isolated solids, Ti−O(alkoxy) (or Ti−Cl) bonds cleave upon hydrolysis, leading to several structural forms, including oligomers. Ionic Q species with no Ti, i.e., obtained after Ti−Q cleavage, are seen for some Ti−Q derivatives by ESI‐MS, which also indicates a varied nuclearity for a given species, e.g., the isolated polynuclear [Q2Ti‐μ‐O]n has several “n” values. Mononuclear Ti complexes are obtained under rigorous anhydrous conditions. The cis structures of the mononuclear species (QT)2Ti(OCH3)2, QT = 3‐methyl‐4‐(neopentylcarbonyl)‐1‐phenylpyrazol‐5‐onato have been analyzed with DFT methods. A trans influence is a major driving force that accounts for several sets of Ti−O bonds. One of the cis stereoisomers is 56 kcal/mol higher in energy than the other two. In contrast, all (QT)2TiCl2 cis isomers show similar energies. Voltammetry of the mononuclear species (QT)2Ti(OnPr)2 and the antitumor tetranuclear compound [(QB)2Ti‐μ‐O]4, (QB = 4‐benzoyl‐3‐methyl‐1‐phenylpyrazol‐5‐onato) indicate that the TiIV is less prone to reduction to TiIII in the latter (Epc for the TiIV/TiIII couple is −1.71 V and −1.46 V versus Fc+/Fc, respectively). Potential antitumor compounds having a Ti/Q ratio of 1:1 do not disproportionate, unlike the equivalent acetylacetonato derivatives, and are water‐soluble. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)